Djamiatun K et al. |
Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. |
2012 |
PLoS Negl Trop Dis |
pmid:22563509
|
Diercke K et al. |
IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. |
2012 |
J Orofac Orthop |
pmid:22955577
|
Terpos E et al. |
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. |
2011 Nov-Dec |
Clin. Exp. Rheumatol. |
pmid:22032557
|
Arikan F et al. |
C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. |
2011 Mar-Apr |
Int J Oral Maxillofac Implants |
pmid:21483881
|
Crespi R et al. |
Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. |
2011 Jul-Aug |
Int J Oral Maxillofac Implants |
pmid:21841997
|
Franke S et al. |
Advanced glycation end products affect growth and function of osteoblasts. |
2011 Jul-Aug |
Clin. Exp. Rheumatol. |
pmid:21906430
|
Rezg R et al. |
Inhibitors of vascular calcification as potential therapeutic targets. |
2011 Jul-Aug |
J. Nephrol. |
pmid:21688249
|
Reyes-GarcÃa R et al. |
[Cardiovascular disease and bone metabolism]. |
2011 Aug-Sep |
Endocrinol Nutr |
pmid:21775224
|
Wang Y et al. |
LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. |
2011 |
Mol. Cell. Endocrinol. |
pmid:21291955
|
Szulc P et al. |
Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. |
2011 |
J. Clin. Endocrinol. Metab. |
pmid:21565793
|
Zhang M et al. |
EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. |
2011 |
J. Bone Miner. Res. |
pmid:20939055
|
Millard SM et al. |
Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation. |
2011 |
J. Bone Miner. Res. |
pmid:20939063
|
Yang L et al. |
Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. |
2011 |
Chin. Med. J. |
pmid:22088466
|
Reinhard H et al. |
Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. |
2011 |
Cardiovasc Diabetol |
pmid:21801376
|
Jabbar S et al. |
Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. |
2011 |
J. Periodont. Res. |
pmid:20731767
|
Sheng L et al. |
[Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. |
2011 |
Zhongguo Zhong Xi Yi Jie He Za Zhi |
pmid:21812275
|
Yang XY et al. |
[Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21868322
|
Malliga DE et al. |
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. |
2011 |
Wien Med Wochenschr |
pmid:21870142
|
Guo HL et al. |
[Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. |
2011 |
Zhongguo Gu Shang |
pmid:21870401
|
McGrath EE |
OPG/RANKL/RANK pathway as a therapeutic target in cancer. |
2011 |
J Thorac Oncol |
pmid:21849854
|
Findlay DM and Atkins GJ |
Relationship between serum RANKL and RANKL in bone. |
2011 |
Osteoporos Int |
pmid:21850548
|
Harada S and Takahashi N |
[Control of bone resorption by RANKL-RANK system]. |
2011 |
Clin Calcium |
pmid:21814016
|
Tao H et al. |
P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. |
2011 |
PLoS ONE |
pmid:21886782
|
Christoforidis A et al. |
Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. |
2011 |
Haemophilia |
pmid:20825502
|
Embree M et al. |
Role of subchondral bone during early-stage experimental TMJ osteoarthritis. |
2011 |
J. Dent. Res. |
pmid:21917603
|
Hope S et al. |
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. |
2011 |
J Psychiatr Res |
pmid:21889167
|
Shin M et al. |
The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. |
2011 |
Carcinogenesis |
pmid:21890459
|
Grigoropoulou P et al. |
The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. |
2011 |
Curr. Med. Chem. |
pmid:21919846
|
Riancho JA and Delgado-Calle J |
[Osteoblast-osteoclast interaction mechanisms]. |
2011 |
Reumatol Clin |
pmid:21924211
|
Peng S et al. |
The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. |
2011 |
Bone |
pmid:21925296
|
Fan R et al. |
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells. |
2011 |
Chin. Med. J. |
pmid:21933620
|
Osorio A et al. |
Mineral-bone metabolism markers in young hemodialysis patients. |
2011 |
Clin. Biochem. |
pmid:21933667
|
Khoshniat S et al. |
Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. |
2011 |
Bone |
pmid:21147284
|
Durual S et al. |
Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. |
2011 |
Clin Oral Implants Res |
pmid:21087318
|
Ashley DT et al. |
Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. |
2011 |
Metab. Clin. Exp. |
pmid:21087777
|
Campbell GM et al. |
Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. |
2011 |
Osteoporos Int |
pmid:20480144
|
Tekkesin MS et al. |
The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. |
2011 |
Head Neck Pathol |
pmid:21643971
|
Jiang JQ et al. |
Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. |
2011 |
Nephrology (Carlton) |
pmid:21649792
|
Choi EM |
Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. |
2011 |
Int. Immunopharmacol. |
pmid:21621646
|
Ueland T et al. |
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. |
2011 |
J. Intern. Med. |
pmid:21623962
|
Wheater G et al. |
Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. |
2011 |
Osteoporos Int |
pmid:21625887
|
Karadag-Saygi E et al. |
The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. |
2011 |
Gynecol. Endocrinol. |
pmid:21627558
|
Taylor R et al. |
Osteoclast formation and function in pigmented villonodular synovitis. |
2011 |
J. Pathol. |
pmid:21706481
|
Conaway HH et al. |
Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. |
2011 |
J. Biol. Chem. |
pmid:21715325
|
Colombini A et al. |
Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. |
2011 |
Int Orthop |
pmid:20623281
|
Kanayama K et al. |
Osteoclast and osteoblast activities on carbonate apatite plates in cell cultures. |
2011 |
J Biomater Appl |
pmid:20624844
|
Cao H et al. |
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. |
2011 |
Circ. J. |
pmid:22001292
|
Scialla JJ et al. |
Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. |
2011 |
Clin J Am Soc Nephrol |
pmid:21940840
|
Baloul SS et al. |
Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. |
2011 |
Am J Orthod Dentofacial Orthop |
pmid:21435543
|
Sfiridaki K et al. |
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment. |
2011 |
Mediators Inflamm. |
pmid:21941412
|
Wang AY |
Consequences of chronic inflammation in peritoneal dialysis. |
2011 |
Semin. Nephrol. |
pmid:21439430
|
Bao L et al. |
Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. |
2011 |
Chem. Biol. Interact. |
pmid:21945525
|
Ikeda K et al. |
Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. |
2011 |
FEBS Lett. |
pmid:21439958
|
Zhou XW et al. |
[Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:21945761
|
Teramachi J et al. |
Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. |
2011 |
Lab. Invest. |
pmid:21339747
|
Carmona-Fernandes D et al. |
Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. |
2011 |
Arthritis Res. Ther. |
pmid:22027240
|
Katz J et al. |
Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. |
2011 |
Int J Oral Maxillofac Surg |
pmid:21396799
|
Wang Y et al. |
[Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:22027773
|
Bitto A et al. |
Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. |
2011 |
Phytomedicine |
pmid:21397481
|
Wang JZ et al. |
[Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats]. |
2011 |
Nan Fang Yi Ke Da Xue Xue Bao |
pmid:22027774
|
Di Bartolo BA et al. |
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. |
2011 |
Cardiovasc. Res. |
pmid:21447702
|
Ho TY et al. |
Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. |
2011 |
Bone |
pmid:21419242
|
Chasseraud M et al. |
Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. |
2011 |
Ther Apher Dial |
pmid:21426505
|
Hsieh TP et al. |
Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. |
2011 |
Phytomedicine |
pmid:20554188
|
Yener S et al. |
Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? |
2011 |
J. Endocrinol. Invest. |
pmid:20530985
|
Hall J et al. |
A controlled clinical exploratory study on genetic markers for peri-implantitis. |
2011 |
Eur J Oral Implantol |
pmid:22282733
|
de Souza JA et al. |
Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. |
2011 |
Arch. Oral Biol. |
pmid:21511249
|
Claro T et al. |
Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. |
2011 |
PLoS ONE |
pmid:21525984
|
Giro G et al. |
Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. |
2011 |
J. Oral Maxillofac. Surg. |
pmid:21530046
|
Won KY et al. |
RANK signalling in bone lesions with osteoclast-like giant cells. |
2011 |
Pathology |
pmid:21532526
|
Naot D et al. |
Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. |
2011 |
Bone |
pmid:21515435
|
Aydin H et al. |
Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. |
2011 |
Minerva Endocrinol. |
pmid:21519319
|
Xu ML et al. |
[An update for the research progress of osteoprotegerin on coronary artery disease]. |
2011 |
Zhonghua Xin Xue Guan Bing Za Zhi |
pmid:22321243
|
Altinova AE et al. |
Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. |
2011 |
Scand. J. Clin. Lab. Invest. |
pmid:21486111
|
Mercatali L et al. |
Bone metastases detection by circulating biomarkers: OPG and RANK-L. |
2011 |
Int. J. Oncol. |
pmid:21491082
|
Huang CH et al. |
Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. |
2011 |
Rheumatology (Oxford) |
pmid:20974615
|
Pepene CE et al. |
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. |
2011 |
Eur. J. Endocrinol. |
pmid:20974706
|
Akinci B et al. |
Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. |
2011 |
Diabetes Res. Clin. Pract. |
pmid:20970873
|
Toffoli B et al. |
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. |
2011 |
Mol. Cell. Endocrinol. |
pmid:20832449
|
Kawaguchi H |
[Approach for therapeutic targets of osteoarthritis]. |
2011 |
Nippon Yakurigaku Zasshi |
pmid:21747205
|
Rauch A et al. |
An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. |
2011 |
FASEB J. |
pmid:21233489
|
Ueland T et al. |
Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. |
2011 |
Circ Heart Fail |
pmid:21216833
|
Hou WW et al. |
Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. |
2011 |
J Orthop Sci |
pmid:21833614
|
Tang T et al. |
Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. |
2011 |
Biomed Mater |
pmid:21205994
|
Attia EA et al. |
Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. |
2011 |
Int. J. Dermatol. |
pmid:21182499
|
Sun Z and Tee BC |
Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. |
2011 |
Anat Rec (Hoboken) |
pmid:21157918
|
Cannon JG et al. |
Follicle-stimulating hormone promotes RANK expression on human monocytes. |
2011 |
Cytokine |
pmid:21159522
|
Choe JY et al. |
Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. |
2011 |
J. Rheumatol. |
pmid:21159831
|
Basu R et al. |
Effects of physiological variations in circulating insulin levels on bone turnover in humans. |
2011 |
J. Clin. Endocrinol. Metab. |
pmid:21325461
|
Kamiya N et al. |
Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. |
2011 |
Int. J. Clin. Oncol. |
pmid:21327451
|
Eslami B et al. |
Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. |
2011 |
Calcif. Tissue Int. |
pmid:21327765
|
Jørgensen L et al. |
Serum osteoprotegerin levels are related to height loss: the Tromsø Study. |
2011 |
Eur. J. Epidemiol. |
pmid:21331661
|
Yuan H et al. |
Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. |
2011 |
J. Clin. Periodontol. |
pmid:22092474
|
Mai QG et al. |
Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. |
2011 |
J. Cell. Biochem. |
pmid:21618594
|
Garcia VG et al. |
Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. |
2011 |
J. Clin. Periodontol. |
pmid:22092666
|
Kornak U |
Animal models with pathological mineralization phenotypes. |
2011 |
Joint Bone Spine |
pmid:21550285
|
Santini D et al. |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
2011 |
PLoS ONE |
pmid:21559440
|
Hen K et al. |
[Osteoprotegerin--a new atherosclerosis marker]. |
2011 |
Pol. Merkur. Lekarski |
pmid:22097184
|
Mariúba MV et al. |
Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. |
2011 |
Braz. J. Med. Biol. Res. |
pmid:21584440
|
Tang Y et al. |
Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. |
2011 |
J Endod |
pmid:22099899
|